FDA grants priority review for Nefecon, for patients with IgA nephropathy
STOCKHOLM, April 28, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the U.S. ...
Tag: FDA
FDA Approves Device That May Help Prevent Traumatic Brain Injuries by Clamping Blood Vessels in the Neck
The US Food and Drug Administration approved a device last week that may help prevent traumatic brain injuries in ...
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today ...
FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) announced receipt of feedback to its Type B ...
Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including
Interim report for H1 2020 Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas ...
